Clariant Beats Earnings Estimates Despite Middle East Disruption

Clariant, a Swiss specialty chemicals maker, has reported better-than-expected second-quarter earnings despite disruption in its high-margin Catalysts unit due to Middle East turmoil. The company's adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose by 1.5% to 171.1 million Swiss francs, beating analysts' forecast of 152 million francs.

The strong results were largely driven by the performance of Care Chemicals and Adsorbents & Additives units, which helped cushion the impact of regional shocks on demand and costs. CEO Conrad Keijzer noted that customers are prioritizing supply reliability over price in specialty chemicals, where tailored products often take precedence over interchangeable ones.

To achieve these savings, Clariant has implemented a 100 million-franc cost-cutting plan, with the goal of reaching an annual run-rate by 2027. This move is expected to boost profitability even if end-markets remain volatile, as fixed costs will be spread across more sales. The company's management also reaffirmed its 2026 sales and margin targets.